Form 4 holding
Director
Apellis Pharmaceuticals, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- $507,804
- Report date
- 14 May 2026
- Price
- $33.00
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount